ArticleThoracic cancer2021

Response to: Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutations.

Fabrizio Citarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.